reshapelifesciences.com (RSLS) - Long-Term Debt to Capital Coefficient

Corporate emblem and logo of ReShape Lifesciences, Inc. (RSLS)

The financial price visualization for ReShape Lifesciences (RSLS) on GURU.Markets reflects debt dynamics, which currently stand at 0.00. The business relies on the automated production of sterile weight-loss systems. ReShape Lifesciences is developing therapeutic solutions through alliances with bariatric centers, implementing safe Lap-Band methods. However, the firm is currently fighting for survival, losing ground due to the expansion of modern weight-loss drugs.

RSLS reshapelifesciences.com: Long-Term Debt to Equity in the range 07/04/2022 - 08/30/2025

Analytical breakdowns for ReShape Lifesciences

- share price and consensus valuation forecast:
Price ReShape Lifesciences Inc|RSLS - Analyst Consensus Forecast
- market capitalization indicators:
Market Value ReShape Lifesciences Inc.|RSLS - Enterprise Value
- balance sheet net asset value indicators:
Net Asset Value per Share ReShape Lifesciences|RSLS - Company Book Value|Market Value to Book Value reshapelifesciences.com|RSLS - Company Total Assets
- debt and solvency information:
Total Debt to Capital ReShape Lifesciences|RSLS - Long-Term Debt to Equity|Current Liabilities to Equity ReShape Lifesciences Inc|RSLS - Company Aggregate Debts|Debts to Book Value ReShape Lifesciences Inc.|RSLS - Company Long-Term Liabilities|Company Short-Term Debts ReShape Lifesciences|Intermediate Liquidity Ratio reshapelifesciences.com
- business earnings and investment ratios data:
RSLS - Net Profit
Summary company analysis:RSLS (reshapelifesciences.com)
Core merchandise of ReShape Lifesciences, Inc.

For ReShape Lifesciences (RSLS), the balance of borrowed funds determines the ability to scale the niche production of Lap-Band systems. This long-term financial debt sustainability metric compares liabilities with maturities exceeding one year against equity. Daily calculations reveal leverage dynamics faster than quarterly reports. Low values confirm protection against default, yet excessive conservatism may slow expansion. It is critical for investors to assess this leverage to understand the pace of business development.

Competing companies

DXCM (DexCom Inc) - Long-Term Loans to Capital Ratio|Long-Term Debt to Capital PEN|NOVT (Novanta Photonics) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital HAE (Haemonetics Corporation)|inspiresleep.com (INSP) - Long-Term Liabilities to Capital|PRCT - Long-Term Debt to Equity|Long-Term Debt to Capital Coefficient CNMD (CONMED Corp)|PLSE: Long-Term Debt to Capital|InMode MD (INMD) - Long-Term Debt to Capital|Long-Term Debt to Equity Picard Medical Inc|surmodics.com - Long-Term Liabilities to Equity|Long-Term Debt to Capital SENS|NPCE - Long-Term Liabilities to Capital|Tactile Medical - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital SANUWAVE Health Inc SNWV|OM: Long-Term Debt to Equity Ratio|Electromed, Inc. - Long-Term Loans to Capital Ratio|LNSR: Long-Term Debt to Capital|RCEL - Ratio of Long-Term Indebtedness to Capital|PROF (Profound Medical Corp) - Long-Term Debt to Capital|Long-Term Debt to Equity Ratio Baird Medical Corp (BDMD)|Long-Term Debt to Equity Ratio EDAP (EDAP TMS S.A.)|APYX (apyxmedical.com) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Equity IceCure Medical ICCM|LUNG - Long-Term Debt to Equity Ratio|TELA Bio Corp - Long-Term Debt to Capital|Long-Term Liabilities to Capital Cytosorbents|SRTS: Long-Term Debt to Capital|Long-Term Debt to Capital Ratio ZYXI|ECOR (electroCore Inc) - Long-Term Debt to Capital|Vicarious Surgical Corp (RBOT) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Capital IINN|Long-Term Debt to Equity Ratio SeaStar Medical Holding Corp. ICU|Long-Term Debt to Capital IRIX (IRIDEX)|Long-Term Debt to Capital Intelligent Bio Solutions Inc INBS|XAIR - Long-Term Debt to Equity|PFSA: Long-Term Debt to Equity|SSKN (strataskinsciences.com) - Long-Term Debt to Equity Ratio|GlucoTrack Inc. - Long-Term Debt to Capital Coefficient|NAOV (NanoVibronix, Inc.) - Long-Term Debt to Capital|Long-Term Liabilities to Capital venusconcept.com VERO|Long-Term Debt to Equity Nuwellis (NUWE)|Aethlon Medical Inc (AEMD) - Long-Term Indebtedness to Equity|Asensus Surgical - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Avinger Inc AVGR|BioSig - Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital cutera.com CUTR|Know Labs (KNW) - Long-Term Debt to Equity|Long-Term Liabilities to Equity NARI (Inari Medical Inc)|Long-Term Debt to Equity Nevro Corporation|Long-Term Debt to Equity Ratio Silk Road Medical Inc (SILK)